# Identification of Biomarkers for Early Detection of Pancreatic Cancer

> **NCT00897494** · — · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 75 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **GENETIC:** protein expression analysis
- **OTHER:** laboratory biomarker analysis
- **OTHER:** mass spectrometry
- **OTHER:** surface-enhanced laser desorption/ionization-time of flight mass spectrometry

## Key facts

- **NCT ID:** NCT00897494
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2009-11
- **Final completion:** 2011-04
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2016-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00897494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00897494, "Identification of Biomarkers for Early Detection of Pancreatic Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00897494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*